Literature DB >> 18402388

Primary anaplastic ganglioglioma with a small-cell glioblastoma component.

J Schittenhelm1, G Reifenberger, R Ritz, T Nägele, M Weller, G Pantazis, D Capper, R Beschorner, R Meyermann, M Mittelbronn.   

Abstract

Gangliogliomas usually present as benign tumors corresponding to World Health Organization (WHO) Grade I. Very rarely, gangliogliomas show histological features of malignancy and are then classified as anaplastic gangliogliomas of WHO Grade III or IV. In most cases, anaplastic gangliogliomas developed after radiation therapy or progression from a pre-existing low-grade ganglioglioma. Here, we report the case of a 77-year-old male patient who was operated on a primary ganglioglioma with a highly anaplastic glial component corresponding to a small-cell glioblastoma. To our knowledge, this is the first reported case of a primary anaplastic ganglioglioma with a small-cell glioblastoma component.

Entities:  

Mesh:

Year:  2008        PMID: 18402388     DOI: 10.5414/npp27091

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  4 in total

Review 1.  Malignant ganglioglioma: case report and review of literature.

Authors:  Ryan DeMarchi; Suzy Abu-Abed; David Munoz; R Loch Macdonald
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

2.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

3.  Treatment and outcomes for gangliogliomas: a single-center review of 16 patients.

Authors:  Jye Young Song; Jeong Hoon Kim; Young Hyun Cho; Chang Jin Kim; Eun Jung Lee
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

4.  Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.

Authors:  Yujiao Wang; Leiming Wang; Ingmar Blümcke; Weiwei Zhang; Yongjuan Fu; Yongzhi Shan; Yueshan Piao; Guoguang Zhao
Journal:  Brain Pathol       Date:  2021-08-05       Impact factor: 6.508

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.